These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10701084)

  • 41. Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis.
    Chasset F; Bouaziz JD; Costedoat-Chalumeau N; Francès C; Arnaud L
    Br J Dermatol; 2017 Jul; 177(1):188-196. PubMed ID: 28112801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Miscellaneous treatments, I: sulfasalazine and pentoxifylline: unapproved uses, dosages, or indications.
    Wolf R; Matz H; Orion E; Tüzün B; Tüzün Y
    Clin Dermatol; 2002; 20(5):531-46. PubMed ID: 12435524
    [No Abstract]   [Full Text] [Related]  

  • 43. Interferons: unapproved uses, dosages, or indications.
    Orion E; Matz H; Wolf R
    Clin Dermatol; 2002; 20(5):493-504. PubMed ID: 12435520
    [No Abstract]   [Full Text] [Related]  

  • 44. Antimalarial therapy for granuloma annulare: Results of a retrospective analysis.
    Grewal SK; Rubin C; Rosenbach M
    J Am Acad Dermatol; 2017 Apr; 76(4):765-767. PubMed ID: 28325398
    [No Abstract]   [Full Text] [Related]  

  • 45. Oral disorders: unapproved treatments or indications.
    Tüzün B; Tüzün Y; Wolf R
    Clin Dermatol; 2000; 18(2):197-200. PubMed ID: 10742629
    [No Abstract]   [Full Text] [Related]  

  • 46. Collagen vascular diseases: unapproved treatments or indications.
    Ghersetich I; Spallanzani A; Bianchi B; Lotti TM
    Clin Dermatol; 2000; 18(2):187-90. PubMed ID: 10742627
    [No Abstract]   [Full Text] [Related]  

  • 47. Alopecia: unapproved treatments or indications.
    Sawaya ME; Shapiro J
    Clin Dermatol; 2000; 18(2):177-86. PubMed ID: 10742626
    [No Abstract]   [Full Text] [Related]  

  • 48. Drugs and other product choices.
    Hyman PM; Carvajal R
    Dermatol Ther; 2009; 22(3):216-24. PubMed ID: 19453345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydroxychloroquine induces autophagic cell death of human dermal fibroblasts: implications for treating fibrotic skin diseases.
    Oikarinen A
    J Invest Dermatol; 2009 Oct; 129(10):2333-5. PubMed ID: 19749781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug treatments for skin disease introduced in 2009.
    Skin Therapy Lett; 2010 Feb; 15(2):6-7. PubMed ID: 20361170
    [No Abstract]   [Full Text] [Related]  

  • 51. Management of antimalarial-refractory cutaneous lupus erythematosus.
    Callen JP
    Lupus; 1997; 6(2):203-8. PubMed ID: 9061669
    [No Abstract]   [Full Text] [Related]  

  • 52. Antimalarial agents and lupus.
    Wallace DJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):243-63. PubMed ID: 8153401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atopic dermatitis: unapproved treatments or indications.
    Graham-Brown R
    Clin Dermatol; 2000; 18(2):153-8. PubMed ID: 10742623
    [No Abstract]   [Full Text] [Related]  

  • 54. Antimalarial treatment of rheumatoid arthritis: 1985 status.
    Rynes RI
    J Rheumatol; 1985 Aug; 12(4):657-9. PubMed ID: 4057186
    [No Abstract]   [Full Text] [Related]  

  • 55. Intralesional chloroquine for the treatment of cutaneous sarcoidosis.
    Liedtka JE
    Int J Dermatol; 1996 Sep; 35(9):682-3. PubMed ID: 8876312
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of synthetic antimalarials in dermatology].
    Arnerić S
    Vojnosanit Pregl; 1967 Dec; 24(12):651-3. PubMed ID: 5590267
    [No Abstract]   [Full Text] [Related]  

  • 57. Unapproved uses of approved drugs.
    Coté CJ
    Paediatr Anaesth; 1997; 7(2):91-2. PubMed ID: 9188107
    [No Abstract]   [Full Text] [Related]  

  • 58. Skin neoplasias including cutaneous lymphoma, melanoma, and others: unapproved treatments or indications.
    Abel EA
    Clin Dermatol; 2000; 18(2):201-10. PubMed ID: 10742630
    [No Abstract]   [Full Text] [Related]  

  • 59. Topical Drug Innovation From 2000 Through 2014.
    Walter JR; Xu S
    JAMA Dermatol; 2015 Jul; 151(7):792-4. PubMed ID: 25807060
    [No Abstract]   [Full Text] [Related]  

  • 60. Psoriasis, lichen planus, and disorders of keratinization: unapproved treatments or indications.
    Capella GL; Finzi AF
    Clin Dermatol; 2000; 18(2):159-69. PubMed ID: 10742624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.